Brokerages forecast that CME Group Inc (NASDAQ:CME) will post sales of $883.58 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for CME Group’s earnings, with the lowest sales estimate coming in at $878.90 million and the highest estimate coming in at $888.43 million. CME Group posted sales of $912.90 million in the same quarter last year, which suggests a negative year over year growth rate of 3.2%. The business is expected to report its next quarterly earnings report before the market opens on Thursday, February 1st.
According to Zacks, analysts expect that CME Group will report full year sales of $883.58 million for the current financial year, with estimates ranging from $3.62 billion to $3.63 billion. For the next year, analysts expect that the business will post sales of $3.85 billion per share, with estimates ranging from $3.77 billion to $3.95 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow CME Group.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The business had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.05 earnings per share.
CME has been the subject of several research reports. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Citigroup boosted their price target on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research note on Tuesday, January 2nd. Wells Fargo & Co boosted their price target on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research note on Wednesday, October 4th. Finally, Barclays boosted their price target on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 10th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. CME Group currently has a consensus rating of “Buy” and an average price target of $144.22.
In other CME Group news, CFO John W. Pietrowicz sold 7,500 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $151.50, for a total value of $1,136,250.00. Following the completion of the transaction, the chief financial officer now owns 32,376 shares in the company, valued at $4,904,964. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 2,600 shares of the company’s stock in a transaction on Friday, November 17th. The shares were sold at an average price of $139.57, for a total transaction of $362,882.00. Following the completion of the transaction, the insider now owns 22,301 shares of the company’s stock, valued at approximately $3,112,550.57. The disclosure for this sale can be found here. In the last quarter, insiders have sold 42,603 shares of company stock valued at $6,250,726. Insiders own 0.57% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Capital International Investors boosted its stake in CME Group by 11.4% in the third quarter. Capital International Investors now owns 12,489,045 shares of the financial services provider’s stock valued at $1,694,514,000 after acquiring an additional 1,279,058 shares in the last quarter. Janus Henderson Group PLC boosted its stake in CME Group by 13,530.7% in the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock valued at $770,227,000 after acquiring an additional 6,104,897 shares in the last quarter. Thornburg Investment Management Inc. boosted its stake in CME Group by 5.4% in the third quarter. Thornburg Investment Management Inc. now owns 3,902,886 shares of the financial services provider’s stock valued at $529,544,000 after acquiring an additional 200,483 shares in the last quarter. APG Asset Management N.V. boosted its stake in CME Group by 10.7% in the third quarter. APG Asset Management N.V. now owns 2,021,128 shares of the financial services provider’s stock valued at $274,227,000 after acquiring an additional 196,171 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. boosted its stake in CME Group by 5.5% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,711,123 shares of the financial services provider’s stock valued at $249,910,000 after acquiring an additional 89,480 shares in the last quarter. Institutional investors own 82.78% of the company’s stock.
CME Group (CME) traded up $2.07 during trading hours on Friday, hitting $154.28. 1,558,652 shares of the company’s stock traded hands, compared to its average volume of 1,350,000. The firm has a market capitalization of $53,210.00, a P/E ratio of 34.98, a price-to-earnings-growth ratio of 2.05 and a beta of 0.72. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group has a fifty-two week low of $114.82 and a fifty-two week high of $155.29.
The company also recently announced a dividend, which was paid on Tuesday, January 16th. Investors of record on Thursday, December 28th were paid a dividend of $3.50 per share. The ex-dividend date was Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s payout ratio is presently 59.86%.
COPYRIGHT VIOLATION WARNING: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/20/883-58-million-in-sales-expected-for-cme-group-inc-cme-this-quarter.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Get a free copy of the Zacks research report on CME Group (CME)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.